<unk>  refers to a regimen consisting of rituximab, gemcitabine, cyclophosphamide, vincristine (Oncovin), and prednisone used to treat both indolent and aggressive forms of diffuse large B-cell lymphoma.
R-GCVP regimen
R-CVP regimen
ACVBP-R regimen
TAC regimen
RCD regimen
MVAC regimen
FMC-R regimen
CBV regimen